Categories AlphaGraphs, Earnings, Health Care
Abbott Laboratories (ABT) Q1 2025 Earnings: Key financials and quarterly highlights
Abbott Laboratories (NYSE: ABT) reported its first quarter 2025 earnings results today.
Total sales increased 4% year-over-year to $10.35 billion. Organic sales growth was 6.9%.
Net earnings grew 8.2% to $1.32 billion compared to last year. GAAP earnings per share increased 8.6% to $0.76 while adjusted EPS rose 11.2% to $1.09.
Abbott expects full-year 2025 organic sales growth to be 7.5-8.5% and adjusted EPS to be $5.05-5.25. For the second quarter of 2025, adjusted EPS is expected to be $1.23-1.27.
Prior performance
Listen to the conference calls as they happen. Don't miss a beat! With AlphaStreet Intelligence, you can listen to live calls and interviews as they happen, so you never have to worry about missing out on important information.
Most Popular
CCL Earnings: Highlights of Carnival Corporation’s Q4 2025 results
Cruise operator Carnival Corporation & plc (NYSE: CCL) on Friday reported an increase in revenue and adjusted earnings for the fourth quarter of fiscal 2025. Earnings topped analysts' expectations. Revenues
Lamb Weston (LW) Q2 2026 Earnings: Key financials and quarterly highlights
Lamb Weston Holdings, Inc. (NYSE: LW) reported its second quarter 2026 earnings results today. Net sales inched up 1% year-over-year to $1.62 billion. Net sales at constant currency remained flat.
Paychex reports higher Q2 FY26 revenue and earnings; EPS beats estimates
Paychex Inc. (NASDAQ: PAYX) on Friday reported stronger-than-expected adjusted earnings for the second quarter of fiscal 2026. Revenues grew 18% year-over-year. The Rochester-based human capital management solutions provider reported revenues
